Picture of virus under microscope

Research under the microscope...

The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs.

Strathprints serves world leading Open Access research by the University of Strathclyde, including research by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), where research centres such as the Industrial Biotechnology Innovation Centre (IBioIC), the Cancer Research UK Formulation Unit, SeaBioTech and the Centre for Biophotonics are based.

Explore SIPBS research

Dietetic management of pediatric overweight : development and description of a practical and evidence-based behavioral approach

Stewart, L. and Houghton, Jan and Hughes, Adrienne and Pearson, Dympna and Reilly, John J (2005) Dietetic management of pediatric overweight : development and description of a practical and evidence-based behavioral approach. Journal of the American Dietetic Association, 105 (11). pp. 1810-1815. ISSN 0002-8223

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

There is great uncertainty over how to treat childhood overweight. Recent systematic reviews provide a consensus on the most promising elements of treatment, but no successful, generalizable, evidence-based treatment model is currently available. We describe a novel approach to treatment that is evidence-based, putting recommendations of recent systematic reviews into practice. The novel treatment uses a client-centered approach and behavioral change techniques to increase and maintain motivation for lifestyle change. It focuses on increasing physical activity, reducing sedentary behavior, and changing diet in children who are overweight (body mass index >98th percentile) and of elementary school age. Treatment lasts for 6 months and requires 5 to 6 hours of a dietetics professional’s time per patient (in contrast to more traditional, less intensive approaches in the United Kingdom, which invest approximately 1.5 hours per patient). Preliminary assessment of the program suggests that it is practical, and patient dropout is low. Formal evaluation of efficacy will not be available until completion of a randomized, controlled trial in 2006. This description of our novel treatment will enhance generalizability of the program if it is successful, and a detailed description will assist in development of other treatments even if it is unsuccessful.